A critical role of IL-6 in the animal model of MS, EAE, has been demonstrated by a number of studies: systemic IL-6 KO mice are resistant to EAE [9,10,11,12,13], and neutralization of IL-6 with antibodies leads to a reduced disease [22], by not well-defined mechanisms. Here, IL6 is linked to myeloid sarcoma.